|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Knowlton Calvin H
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-02-07 Sale |
2019-02-11 8:04 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
8,000 | $52.73 | $421,871 | 843,019 (Indirect Direct) |
View |
| 2019-01-17 Sale |
2019-01-23 08:35 am |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
8,000 | $64.65 | $517,194 | 844,419 (Direct Indirect) |
View |
| 2019-01-07 Sale |
2019-01-09 6:04 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
8,000 | $63.06 | $504,441 | 848,019 (Indirect Direct) |
View |
| 2018-12-18 Sale |
2018-12-21 08:16 am |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
8,000 | $63.63 | $509,024 | 852,419 (Direct Indirect) |
View |
| 2018-12-12 Sale |
2018-12-14 5:45 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
8,000 | $75.87 | $606,929 | 853,980 (Indirect Direct) |
View |
| 2018-11-19 Sale |
2018-11-21 4:12 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
8,000 | $61.68 | $493,419 | 851,399 (Direct Indirect) |
View |
| 2018-11-12 Purchase |
2018-11-14 4:17 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
7,500 | $65 | $487,529 | 851,399 (Indirect Direct) |
View |
| 2018-11-07 Sale |
2018-11-08 6:09 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
8,000 | $72.13 | $577,045 | 851,099 (Indirect Direct) |
View |
| 2018-10-17 Sale |
2018-10-19 4:49 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
8,000 | $81.01 | $648,045 | 851,899 (Direct Indirect) |
View |
| 2018-10-08 Sale |
2018-10-10 4:11 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
8,000 | $74.22 | $593,727 | 859,499 (Indirect Direct) |
View |
| 2018-09-17 Sale |
2018-09-19 4:19 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
8,000 | $79.8 | $638,362 | 859,899 (Direct Indirect) |
View |
| 2018-09-07 Sale |
2018-09-10 6:08 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
8,000 | $85.98 | $687,825 | 867,099 (Indirect Direct) |
View |
| 2018-08-17 Sale |
2018-08-21 5:21 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
8,000 | $72.23 | $577,830 | 867,899 (Direct Indirect) |
View |
| 2018-08-07 Sale |
2018-08-09 4:31 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
8,000 | $60.54 | $484,281 | 868,839 (Indirect Direct) |
View |
| 2018-07-17 Sale |
2018-07-18 6:21 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
8,000 | $67.48 | $539,850 | 875,899 (Direct Indirect) |
View |
| 2018-07-09 Sale |
2018-07-10 5:26 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
8,000 | $68.21 | $545,644 | 881,345 (Indirect Direct) |
View |
| 2018-06-18 Sale |
2018-06-20 4:39 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
8,000 | $60.28 | $482,240 | 883,899 (Direct Indirect) |
View |
| 2018-06-07 Sale |
2018-06-07 9:11 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
8,000 | $53.94 | $431,505 | 887,274 (Indirect Direct) |
View |
| 2018-05-17 Sale |
2018-05-18 8:29 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
8,000 | $50.19 | $401,515 | 891,899 (Direct Indirect) |
View |
| 2018-05-07 Sale |
2018-05-09 4:06 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
8,000 | $42.79 | $342,320 | 891,899 (Indirect Direct) |
View |
| 2018-04-09 Sale |
2018-04-10 6:11 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
8,000 | $38.69 | $309,537 | 903,706 (Indirect Direct) |
View |
| 2018-03-07 Sale(A) |
2018-04-10 6:10 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
8,000 | $35.59 | $284,714 | 912,770 (Indirect Direct) |
View |
| 2018-03-07 Sale |
2018-03-08 4:33 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
8,000 | $35.59 | $284,714 | 833,733 (Indirect Direct) |
View |
| 2018-02-07 Sale |
2018-02-07 4:28 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
8,000 | $34.75 | $278,000 | 836,862 (Indirect Direct) |
View |
| 2018-01-08 Sale |
2018-01-09 4:25 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO, 10% Owner |
8,000 | $32.75 | $262,000 | 844,862 (Indirect Direct) |
View |
| 2017-12-07 Sale |
2017-12-11 5:08 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO, 10% Owner |
123,000 | $25.97 | $3,194,510 | 910,362 (Direct Indirect) |
View |
| 2017-10-18 Sale |
2017-10-19 6:39 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO, 10% Owner |
8,000 | $26.68 | $213,440 | 918,362 (Direct Indirect) |
View |
| 2017-09-13 Sale |
2017-09-14 5:07 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO, 10% Owner |
8,000 | $22.1 | $176,800 | 918,362 (Direct Indirect) |
View |
| 2017-08-16 Sale |
2017-08-17 5:20 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO, 10% Owner |
8,000 | $17.21 | $137,680 | 918,362 (Direct Indirect) |
View |
| 2017-07-19 Sale |
2017-07-21 1:56 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO, 10% Owner |
8,000 | $14.2 | $113,600 | 918,362 (Direct Indirect) |
View |
| 2017-06-14 Sale |
2017-06-15 9:51 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO, 10% Owner |
8,000 | $14.02 | $112,160 | 918,362 (Direct Indirect) |
View |
| 2017-05-17 Sale |
2017-05-18 6:26 pm |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO, 10% Owner |
8,000 | $11.94 | $95,520 | 918,362 (Direct Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-02-14 Option Award |
2019-02-15 6:10 pm |
N/A N/A |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
73,000 | $0 | 909,419 (Direct) |
View |
| 2019-02-14 Option Award |
2019-02-15 6:10 pm |
N/A N/A |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
55,000 | $0 | 909,419 (Indirect) |
View |
| 2018-12-24 Gift |
2018-12-27 4:31 pm |
N/A N/A |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
50,300 | $0 | 852,419 (Indirect) |
View |
| 2018-12-24 Gift |
2018-12-27 4:31 pm |
N/A N/A |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
10,000 | $0 | 852,419 (Indirect) |
View |
| 2018-12-24 Gift |
2018-12-27 4:31 pm |
N/A N/A |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
10,000 | $0 | 852,419 (Indirect) |
View |
| 2018-11-27 Exercise |
2018-11-29 5:02 pm |
N/A N/A |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
9,020 | $6.41 | 860,419 (Direct) |
View |
| 2018-11-27 Exercise |
2018-11-29 5:02 pm |
N/A N/A |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
9,020 | $6.41 | 860,419 (Indirect) |
View |
| 2018-11-27 Exercise |
2018-11-29 5:02 pm |
N/A 2019-01-01 |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
9,020 | $6.41 | 860,419 (Direct) |
View |
| 2018-11-27 Exercise |
2018-11-29 5:02 pm |
N/A 2019-01-01 |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
9,020 | $6.41 | 860,419 (Indirect) |
View |
| 2018-02-26 Option Award |
2018-02-27 6:32 pm |
N/A N/A |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
2,037 | $0 | 915,899 (Direct) |
View |
| 2018-02-26 Option Award |
2018-02-27 6:32 pm |
N/A N/A |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
1,734 | $0 | 915,899 (Indirect) |
View |
| 2018-01-02 Option Award |
2018-02-27 6:31 pm |
N/A N/A |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
77,000 | $0 | 913,862 (Direct) |
View |
| 2018-01-02 Option Award |
2018-02-27 6:31 pm |
N/A N/A |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
64,000 | $0 | 913,862 (Indirect) |
View |
| 2018-01-02 Option Award |
2018-02-21 5:02 pm |
N/A N/A |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
77,000 | $0 | 913,862 (Direct) |
View |
| 2018-01-02 Option Award |
2018-02-21 5:02 pm |
N/A N/A |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
64,000 | $0 | 913,862 (Indirect) |
View |
| 2016-10-21 Option Award |
2018-01-17 6:33 pm |
N/A 2021-10-21 |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
6,400 | $15.65 | 58,600 (Direct) |
View |
| 2016-10-21 Option Award |
2018-01-17 6:33 pm |
N/A 2026-10-21 |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
58,600 | $15.65 | 58,600 (Direct) |
View |
| 2016-10-21 Option Award |
2018-01-17 6:33 pm |
N/A 2021-10-21 |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
6,400 | $15.65 | 58,600 (Indirect) |
View |
| 2016-10-21 Option Award |
2018-01-17 6:33 pm |
N/A 2026-10-21 |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO |
48,600 | $15.65 | 58,600 (Indirect) |
View |
| 2017-03-10 Option Award |
2017-05-15 8:36 pm |
N/A 2022-03-10 |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO, 10% Owner |
5,900 | $15.16 | 86,600 (Direct) |
View |
| 2017-03-10 Option Award |
2017-05-15 8:36 pm |
N/A 2027-03-10 |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO, 10% Owner |
86,600 | $15.16 | 86,600 (Direct) |
View |
| 2017-03-10 Option Award |
2017-05-15 8:36 pm |
N/A 2022-03-10 |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO, 10% Owner |
5,900 | $15.16 | 86,600 (Indirect) |
View |
| 2017-03-10 Option Award |
2017-05-15 8:36 pm |
N/A 2027-03-10 |
Tabula Rasa HealthCare Inc. | TRHC | Knowlton Calvin H CEO, 10% Owner |
74,100 | $15.16 | 86,600 (Indirect) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Sun, 17 Feb 2019 22:25:33 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |